Results 151 to 160 of about 38,676 (197)

A randomized double-blind placebo-controlled phase I/II clinical trial of a human papillomavirus therapeutic vaccine, PepCan, for reducing head and neck squamous cell carcinoma recurrence. [PDF]

Oncotarget
Bivens E, Atiq O, Evans T, Bimali M, Brown G, Crane J, Darwish N, Faulkner JL, Govindarajan R, Johnson A, Kurilung A, Lazarenko O, Lu YW, Marsh K, Moreno M, Nookaew I, Robeson M, Sunde J, Ussery D, Vural E, Wilman M, Nakagawa M.   +21 more
europepmc   +1 more source

Regulation of HPV-16 infection by ubiquitination of the L1 major capsid protein. [PDF]

J Virol
Trejo-Cerro O, Bergant Marušič M, Wlodarczyk P, Repnik U, Lovšin N, Myers MP, Garcea RL, Banks L, Broniarczyk J.   +8 more
europepmc   +1 more source

HPV, APOBEC3B, and the origins of breast cancer: a narrative review and perspectives on novel mechanisms. [PDF]

Front Oncol
Liu ZY, Chen R.
europepmc   +1 more source

Circular RNA-based HPV16 therapeutic vaccine elicits potent and durable antitumor immunity. [PDF]

J Exp Clin Cancer Res
Zhou R, Li C, Xiang K, Cui L, Rong Y, Li L, Zhu M, Zeng J, Gao L.   +8 more
europepmc   +1 more source

Analysis of tumorigenesis in human papillomavirus transgenic mouse

, 1997
openaire   +1 more source

Immunohistochemical and western blot expression of MMPs, TIMPs, and cytokeratin 10 in feline squamous cell carcinoma. [PDF]

Front Vet Sci
Tutu P, Altamura G, Daraban Bocaneti F, Hritcu OM, Pasca AS, Dascalu MA, Horodincu L, Tanase OI, Mares M, Borzacchiello G.   +9 more
europepmc   +1 more source

Towards Global HPV Eradication: Single-Dose HPV Vaccination vs. Pseudoscience. [PDF]

Pathophysiology
Shiro R, Tsunoda I.
europepmc   +1 more source

mRNA-encoded mutant HPV16/18 vaccines promote specific T-cell responses and synergize with anti-PD-1 checkpoint blockade in mediating therapeutic tumor regression in mice. [PDF]

J Immunother Cancer
Zhang Q, Cao B, Li L, Zhou Y, Ni C, Zhao Y, Xu D, Yu H, Jin L, Zhang Y, Qiao X, Zhang J, Liu S, Zhang X, Liu A, Han H, Ma X, Xu W.   +17 more
europepmc   +1 more source

LILRB4 shapes an immunosuppressive microenvironment to drive cervical cancer progression through tumor-infiltrating myeloid cell expansion and CD8⁺ T-cell suppression. [PDF]

Cell Mol Life Sci
Zhang Y, Gao Y, Guan X, Wang E, Tong R.
europepmc   +1 more source

Mouse Vocal Fold Permeability In Vivo: Effects of Novel Low-Tech Injury and Instillation Methods. [PDF]

Laryngoscope
King RE, Ward-Shaw ET, Lambert PF.
europepmc   +1 more source